Market size continues to grow: With the continuous increase in demand for precision medicine and high-throughput screening, the market size of the microfluidic transmembrane cell impedance industry, which belongs to the cell resistance meter, continues to expand. The market size of China's microfluidic transmembrane cell impedance industry will reach 4.37 billion yuan in 2024, a year-on-year increase of 18.9% compared to 2023, and is expected to further expand to 5.18 billion yuan in 2025, a year-on-year increase of 18.5%.

The application fields are constantly expanding: Cell resistance meters are widely used in biomedical, cell analysis and other fields. In tumor research, it can be used to monitor the migration and invasion of tumor cells; In terms of drug development, real-time monitoring of changes in cell impedance can be used to evaluate the impact of drugs on cells and screen potential drug candidates; In addition, it has important applications in the construction of blood-brain barrier models, myocardial cell toxicity testing, organoid culture, and other fields. With the development of related technologies, its application scope will continue to expand.

Technological innovation drives development: On the one hand, the integrated design of multi-layer microchannels and three-dimensional cell culture chambers enhances the realism of cell microenvironment simulation; On the other hand, impedance signal denoising and feature extraction models based on AI algorithms have been introduced into the data analysis process, resulting in a detection accuracy improvement of over 32%. At the same time, wireless and portable devices have emerged, suitable for rapid on-site detection scenarios, further expanding the application scenarios of cell resistance meters.

The acceleration of domestic substitution process: Domestic enterprises have made breakthroughs in the core sensor design, microfabrication technology, and data analysis algorithms of cell resistance meters, promoting the improvement of product cost-effectiveness. For example, Suzhou Wenhao Microfluidic Technology Co., Ltd. has achieved independent production in the preparation of microelectrode arrays, and Beijing Baikangxin Biotechnology Co., Ltd. has launched the CellXplorer series multifunctional cell impedance analyzer, which has a single unit price nearly 30% lower than imported products. The acceleration of domestic substitution process will provide strong support for the market promotion of cell impedance analyzers.